Aromatase inhibitors and arthralgia: a growing pain?
作者： Maura N. Dickler , Clifford A. Hudis , Conleth Murphy
DOI:
关键词:
摘要: In the current issue of ONCOLOGY, Henry et al comprehensively review state knowledge regarding incidence and pathogenesis aromatase inhibitor (AI)-associated arthralgia, its potential implications in terms delivering adequate, effective adjuvant therapy.
cancernetwork.com参考文章(12)
Ellen W. Freeman, Mary D. Sammel, Hui Lin, Clarisa R. Gracia, Grace W. Pien, Deborah B. Nelson, Li Sheng, Symptoms Associated With Menopausal Transition and Reproductive Hormones in Midlife Women Obstetrics & Gynecology. ,vol. 110, pp. 230- 240 ,(2007) , 10.1097/01.AOG.0000270153.59102.40
C. Fontaine, A. Meulemans, M. Huizing, C. Collen, L. Kaufman, J. De Mey, C. Bourgain, G. Verfaillie, J. Lamote, R. Sacre, D. Schallier, B. Neyns, J. Vermorken, J. De Grève, Tolerance of adjuvant letrozole outside of clinical trials. The Breast. ,vol. 17, pp. 376- 381 ,(2008) , 10.1016/J.BREAST.2008.02.006
Sheila A. Dugan, Lynda H. Powell, Howard M. Kravitz, Susan A. Everson Rose, Kelly Karavolos, Judith Luborsky, Musculoskeletal pain and menopausal status. The Clinical Journal of Pain. ,vol. 22, pp. 325- 331 ,(2006) , 10.1097/01.AJP.0000208249.07949.D5
Raimund Jakesz, Walter Jonat, Michael Gnant, Martina Mittlboeck, Richard Greil, Christoph Tausch, Joern Hilfrich, Werner Kwasny, Christian Menzel, Hellmut Samonigg, Michael Seifert, Guenther Gademann, Manfred Kaufmann, Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial The Lancet. ,vol. 366, pp. 455- 462 ,(2005) , 10.1016/S0140-6736(05)67059-6
Jack Cuzick, Ivana Sestak, Michael Baum, Aman Buzdar, Anthony Howell, Mitch Dowsett, John F Forbes, Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncology. ,vol. 11, pp. 1135- 1141 ,(2010) , 10.1016/S1470-2045(10)70257-6
Cary A. Presant, Linda Bosserman, Traci Young, Mayank Vakil, Richard Horns, Gargi Upadhyaya, Behnam Ebrahimi, Christina Yeon, Frank Howard, Aromatase Inhibitor–Associated Arthralgia and/or Bone Pain: Frequency and Characterization in Non–Clinical Trial Patients Clinical Breast Cancer. ,vol. 7, pp. 775- 778 ,(2007) , 10.3816/CBC.2007.N.038
Eleftherios P Mamounas, Jong-Hyeon Jeong, D Lawrence Wickerham, Roy E Smith, Patricia A Ganz, Stephanie R Land, Andrea Eisen, Louis Fehrenbacher, William B Farrar, James N Atkins, Eduardo R Pajon, Victor G Vogel, Joan F Kroener, Laura F Hutchins, André Robidoux, James L Hoehn, James N Ingle, Charles E Geyer Jr, Joseph P Costantino, Norman Wolmark, None, Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial Journal of Clinical Oncology. ,vol. 26, pp. 1965- 1971 ,(2008) , 10.1200/JCO.2007.14.0228
Ivana Sestak, Jack Cuzick, Francisco Sapunar, Richard Eastell, John F Forbes, Angelo R Bianco, Aman U Buzdar, Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Lancet Oncology. ,vol. 9, pp. 866- 872 ,(2008) , 10.1016/S1470-2045(08)70182-7
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David A. Cameron, Michael J. Palmer, Joseph L. Pater, Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Journal of the National Cancer Institute. ,vol. 97, pp. 1262- 1271 ,(2005) , 10.1093/JNCI/DJI250
Alan S. Coates, Aparna Keshaviah, Beat Thürlimann, Henning Mouridsen, Louis Mauriac, John F. Forbes, Robert Paridaens, Monica Castiglione-Gertsch, Richard D. Gelber, Marco Colleoni, István Láng, Lucia Del Mastro, Ian Smith, Jacquie Chirgwin, Jean-Marie Nogaret, Tadeusz Pienkowski, Andrew Wardley, Erik H. Jakobsen, Karen N. Price, Aron Goldhirsch, Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Journal of Clinical Oncology. ,vol. 25, pp. 486- 492 ,(2007) , 10.1200/JCO.2006.08.8617